黄河附属第一医院 | 医学院临床医学· 造血干细胞移植的临床和基础研究· 干细胞基础及应用研究· 免疫治疗临床基础及应用研究个人简介:        黄河，浙江大学求是特聘教授，973首席科学家，主任医师，博士生导师。现任浙江大学医学院党委书记、副院长，浙江大学血液病研究所所长，浙江大学医学院附属第一医院骨髓移植中心主任。任中华医学会血液学分会造血干细胞应用学组副组长，中华骨髓库专家委员会副主任委员，亚太国际骨髓移植组织国际学术委员会常务委员（中国唯一），浙江省医学会血液专业委员会主任委员，浙江省抗癌协会血液淋巴肿瘤专业委员会主任委员等学术职务。        1984年起从事血液学、造血干细胞移植和干细胞基础与转化研究，先后于2003年及2015年2次荣获国家科技进步奖二等奖。作为负责人承担973，863，国家自然科学基金重点项目，国家自然科学基金国际合作与交流项目等26项。近10年在国内外学术期刊发表论文200余篇，其中在Blood、Leukemia等SCI杂志发表论文139篇（其中通讯作者论文99篇）。获省部级以上奖项14项，授权发明专利17项。近5年在国际大型会议担任主席、特邀报告和口头报告58次。作为大会主席分别于2005年和2014年在杭州主办亚太国际骨髓与造血干细胞移植大会。主编人民卫生出版社第一版和第二版全国研究生《血液内科学》教材，参编著作及教材5部。任国际造血干细胞移植领域权威杂志Bone Marrow Transplantation，Biology of Blood and Marrow Transplantation和Journal of Hematology and Oncology编委。教学与课程:血液学进展（博士研究生课程）血液学专题（博士研究生课程）专业外语（博士研究生课程）血液学进展（硕士研究生课程）血液病进展（硕士研究生课程）专业外语（硕士研究生课程）内科学进展（硕士研究生课程）内科学（本科生课程） 临床带教（本科生课程）内科护理学（本科生课程）科研:主要承担科研项目：1. 国家自然科学基金重点项目（81730008）：CD44/CD49d介导骨髓微环境庇护和MIRL抵抗穿孔素/颗粒酶杀伤途径在CAR-T细胞治疗后急性淋巴细胞白血病CD19阳性复发中的作用和机制（2018-2022）（主持人)，295万2. 国家自然科学基金国际合作与交流项目（81520108002）：WAS-iPSCs突变基因通过CRISPR/Cas9靶向修复并向造血细胞定向分化研究（2016-2020）（主持人)，2823. 国家重点基础研究发展计划（973项目）(2015CB964900): 多能干细胞定向分化为造血干细胞的调控机理及功能研究(2015-2019)(主持人) 689万4. 国家自然科学基金重点项目（81230014）：PTPN21基因突变和以NKG2D为核心的免疫网络失衡在急性淋巴细胞白血病异基因造血干细胞移植后复发中的作用与机制研究 (2012-2017) （主持人），270万5. 国家自然科学基金面上项目（81170501）：CEBPA单基因多点突变致急性白血病发生及其分子机制研究 （2012-2015）（主持人），65万6. 浙江省重大科技专项重点社会发展项目（2012C13021-1）：难治、复发白血病新分子靶标的发现及综合治疗技术的建立（2012-2015）（主持人），100万7. 国家高技术研究发展计划（863计划）子课题（2011AA020117）: 骨髓间充质干细胞新药的研究开发 (2011-2014) （主持人），180万8. 浙江省自然科学基金重点项目（Z2100097）：调控ALT相关PML小体形成蛋白质作用网络的研究（2011-2014）（主持人），40万9. 高等学校博士学科点专项科研博导类基金（20100101110121）：人iPS细胞体外向红细胞诱导分化及其生物学特性的研究（2011-2013）（主持人），8万10. 卫生部科学研究基金（WKJ2011-2-001）：间充质干细胞体内动员及富集分选平台技术的创建 （2011-2013）（主持人），15万11. 国家自然科学基金(30871098)：PML3蛋白及其SUMO化修饰在ALT永生化细胞中的功能及分子机制的研究(2009-2011)（主持人），32万12. 国家自然科学基金(30770919)：一个新的中心体蛋白TACP1在细胞有丝分裂中的功能及分子机制研究(2008-2010)（主持人）30万13. 浙江省医学重点学科：干细胞与组织工程学（2012-2014）（负责人）14. 浙江省医学重点学科：医学组织工程学（2008-2010）（负责人）15. 卫生部行业基金（200802027）：血液恶性肿瘤及造血干细胞移植患者侵袭性真菌感染的早期抗原和分子生物学诊断实验研究（2008-2011）（子课题负责人） 20万16. 浙江省科技厅重大研究计划(2006C13022)：基于干细胞技术的组织工程研究和产品开发(2007-2009)（主持人）100万17. 国家自然科学基金(30570941)：一个新的TRF1 结合蛋白TRF1BP1 的功能及对细胞周期调控机制的研究(2006-2007)（主持人）8万18. 卫 生 部 科 学 研 究 基 金(WKJ2005-2-036)：自体造血干细胞联合非清髓异基因造血干细胞移植治疗多发性骨髓瘤临床研究(2005-2007)（主持人）30万19. 浙江省自然科学基金(R204232)：浙江省自然科学基金青年科技人才培养项目: NK细胞抑制性KIR功能修饰对移植物抗宿主病的影响及机理研究－黄河课题组(2005-2007)（主持人）25万20.国家重点基础规划发展项目973项目子课题(2002CB713704)：调控细胞增殖与肿瘤细胞转移重要蛋白质作用网络研究(2003—2007)（主持人）102万21.浙江省科技厅重点科研项目(2003C23015)：间充质干细胞纯化建系和临床应用(2003-2005)（主持人）20万22. 浙江省九五科技攻关重大项目(001103058)：非亲缘异基因骨髓移植临床研究(2000-2003)（主持人）50万23. 浙江省医药卫生九五攻关重点项目(2000ZD001)：预防非亲缘异基因骨髓移植中急性移植物抗宿主病的临床和实验研究(2000-2002)（主持人）10万24. 浙江省自然科学基金(399141)：急性髓细胞性白血病Tankyrase的表达研究 (2000-2002)（主持人）4万25. 国家自然科学基金(39870339)：急性髓细胞性白血病与人端粒重复序列结合因子(TRF1)突变和表达的研究（1999-2001）（主持人）13万26.  浙江省科技厅（991103181）：人端粒重复序列结合因子单抗制备及检测技术(1999-2000)（主持人）3万研究与成果:所获奖励被授予“浙江省特级专家”称号，2018年4月；被授予“圣安东尼EBMT成就奖（中国）“，2018年7月；异基因造血干细胞移植关键技术创新与推广应用   2015年国家科学技术进步奖二等奖（排名第一）非亲缘异基因骨髓移植临床研究    2003年国家科学技术进步奖二等奖（排名第一）异基因造血干细胞移植重要并发症的预警与诊治新技术   2013年教育部高等学校科学技术进步奖一等奖（排名第一）间充质干细胞与组织工程产品的研发与应用    2011浙江省科学技术奖一等奖（排名第一）慢性粒细胞白血病分子靶向治疗及异基因造血干细胞移植最新策略的的建立与推广    2010浙江省科学技术奖一等奖（排名第一)慢性粒细胞白血病分子靶向治疗及异基因造血干细胞移植最新策略的的建立与推广    2010浙江省医药卫生科技创新奖一等奖（排名第一）多发性骨髓瘤危险度分层新模式的建立及应用研究     2013年浙江省科学技术奖一等奖（排名第十）急性移植物抗宿主病防治的基础和临床研究    2008年浙江省科学技术奖三等奖（排名第三）急性移植物抗宿主病防治的基础和临床研究    2008浙江省医药卫生科技创新奖二等奖（排名第三）人骨髓间充质干细胞纯化建系及临床试验研究    2007年浙江省科学技术奖三等奖（排名第二）骨髓增生异常综合征发病机理及临床研究    2006年浙江省科学技术奖二等奖（排名第三)骨髓增生异常综合征发病机理及临床研究    2006年浙江省医药卫生科技创新奖二等奖（排名第三）人骨髓间充质干细胞特异性单克隆抗体的制备及应用    2006年浙江省医药卫生科技创新奖三等奖（排名第一）人端粒结合因子（TRF1）的临床与基础研究    2003年浙江省科学技术奖二等奖（排名第一）人端粒结合因子（TRF1）的临床与基础研究    2003年浙江省医药卫生科技创新奖二等奖（排名第一）非亲缘异基因骨髓移植临床研究    2002年浙江省科学技术奖一等奖（排名第一）高三尖杉酯碱致白血病细胞凋亡的信号传导和基因调控的研究及其临床意义    2002年浙江省科学技术奖二等奖（排名第五）高三尖杉酯碱致白血病细胞凋亡的信号传导和基因调控的研究及其临床意义    2002年浙江医药卫生科技创新奖一等奖（排名第五）非亲缘异基因骨髓移植临床研究    2001年浙江省医药卫生科技创新奖一等奖（排名第一）脐血CD34+造血干细胞纯化和体外扩增的研究    2001年浙江省医药卫生科技创新奖三等奖（排名第二）血小板血型基础与临床综合研究    2000年浙江省科学技术进步奖三等奖（排名第四）血小板血型基础与临床综合研究    1999年浙江省卫生厅科技奖二等奖（排名第四）人端粒重复序列结合因子的克隆、表达纯化和多抗制备    2000年浙江省卫生厅科技奖二等奖（排名第一）程控冻存对人单个核细胞IL-1IL-2、TNF影响的机理研究    1999年浙江省科学技术进步奖三等奖（排名第二）程控冻存对人单个核细胞IL-1IL-2、TNF影响的机理研究    1999年浙江省卫生厅科技奖二等奖（排名第二）发表论文:1. Yang L Tan Y Shi J Zhao Y Zhu Y Hu Y Pan W Ye Y He J Zheng W Sun J Cai Z Huang H Luo Y. Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma.Bone Marrow Transplant. 2018 Apr 30. (Epub ahead of print)2. Zhang H Liang Z Hu Y Wang X Wang B Huang H*. The effectiveness of interferon-α combined with imatinib in patient with chronic myeloid leukemia harboring T315I BCR-ABL1 mutation. Leuk Lymphoma. 2018 Apr 4:1-2. (Epub ahead of print)3. Liu L Wan X Zhou P Zhou X Zhang W Hui X Yuan X Ding X Zhu R Meng G Xiao H Ma F Huang H Song X Zhou B Xiong S Zhang Y. The chromatin remodeling subunit Baf200 promotes normal hematopoiesis and inhibits leukemogenesis. J Hematol Oncol. 2018 Feb 26;11(1):27. 4. Liu L Yu Q Fu S Wang B Hu K Wang L Hu Y Xu Y Yu X Huang H*. The CXCR4 antagonist AMD3100 promotes mesenchymal stem cell mobilization in rats preconditioned with the hypoxia-mimicking agent cobalt chloride.Stem Cells Dev. 2018 Apr 1;27(7):466-478.5. Wei G Hu Y Pu C Yu J Luo Y Shi J Cui Q Wu W Wang J Xiao L Wu Z Huang H*. CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study. Ann Hematol. 2018 May;97(5):781-789.6. Hu Y Wang J Pu C Zhao K Cui Q Wei G Wu W Xiao L Xiao Y Wang J Wu Z Huang H*. Delayed Terminal Ileal Perforation in a Relapsed/refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy. Cancer Res Treat. 2018 Feb 5. (Epub ahead of print)7. Ding L Hu Y Zhao K Wei G Wu W Wu Z Xiao L Huang H*. Pleural cavity cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy: A case report. Medicine (Baltimore). 2018 Feb;97(7):e9992.8. Shan W Wang B Xu Y Li X Li X Wang H Lin Y Tie R Zhao Q Wang J Zheng W Hu Y Shi J Yu X Huang H*. Generation of hematopoietic cells from mouse pluripotent stem cells in a 3D culture system of self-assembling peptide hydrogel. J Cell Physiol. 2018 Jan 31. (Epub ahead of print)9. Lin Y Wang B Shan W Tan Y Feng J Xu L Wang L Han B Zhang M Yu J Yu X Huang H*. mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation. Clin Immunol. 2018 Feb;187:122-131. 10. Wang B Lin Y Hu Y Shan W Liu S Xu Y Zhang H Cai S Yu X Cai Z Huang H*. mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2. Stem Cell Res Ther. 2017 Dec 29;8(1):292.11. Zhu J Huang H Chen H Zhang X Li Z Wu D Zhou D Song Y Hu Y Liang YRen H Huang H Li N Chen H Hu J Li J Meng R Wu J Yu D Huang X.Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkins lymphoma: a randomized Phase 3 study. Transfusion. 2017 Dec 13. (Epub ahead of print)12. Ye Y Zheng W Wang J Hu Y Luo Y Tan Y Shi J Zhang M Huang H*. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study. Hematol Oncol. 2017 Dec;35(4):821-827.13. Wang J Hu Y Huang H*. Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy. J Leukoc Biol. 2017 Dec;102(6):1347-1356.14. Wei G Wang J Huang H Zhao Y*. Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia. J Hematol Oncol. 2017 Aug 18;10(1):150.15. Zhao Y Wang J Luo Y Shi J Zheng W Tan Y Cai Z Huang H*. Reduced-intensity allogeneic hematopoietic stem cell transplantation combined with imatinib has comparable event-free survival and overall survival to long-term imatinib treatment in young patients with chronic myeloid leukemia. Ann Hematol. 2017 Aug;96(8):1353-1360.16. Liu S Ye Z Gao Y He C Williams DW Moliterno A Spivak J Huang H* Cheng L.Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene. Stem Cell Res. 2017 Jan;18:57-59.17. Santoro N Ruggeri A Labopin M Bacigalupo A Ciceri F Gülbaş Z Huang H Afanasyev B Arcese W Wu D Koc Y Tischer J Santarone S Giebel S Mohty M Nagler A. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. J Hematol Oncol. 2017;10(1):113. 18. Yu J Hu Y Pu C Liang Z Cui Q Zhang H Luo Y Shi J Jin A Xiao L Wu Z Huang H*.Successful chimeric Ag receptor modified T cell therapy for isolated testicular relapse after hematopoietic cell transplantation in an acute lymphoblastic leukemia patient. Bone Marrow Transplant. 2017 Jul;52(7):1065-1067.19. Wei G Ding L Wang J Hu Y Huang H*. Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia. Exp Hematol Oncol. 2017 Apr 14;6:10. 20. Lai R Gu M Jiang W Lin W Xu P Liu Z Huang H An H Wang X*. Raf Kinase Inhibitor Protein Preferentially Promotes TLR3-Triggered Signaling and Inflammation. J Immunol. 2017 May 15;198(10):4086-4095. 21. Ma C Lin W Liu Z Tang W Gautam R Li H Qian Y Huang H Wang X. NDR1 protein kinase promotes IL-17- and TNF-α-mediated inflammation by competitively binding TRAF3. EMBO Rep. 2017 Apr;18(4):586-602. 22. Tan Y Xiao H Wu D Luo Y Lan J Liu Q Yu K Shi J He J Zheng W Lai X Zhu Y Du K Ye Y Zhao Y Zheng G Hu Y Han X Zheng Y Wei G Cai Z Huang H*. Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study. Oncoimmunology. 2017 Jan 6;6(3):e1277307. 23. Han B Zhao Y Lin Y Fu S Wang L Zhang M Tie R Wang B Luo Y Liu L Yu J Huang H*. Hydroxychloroquine sensitizes chronic myeloid leukemia cells to Vγ9Vδ2 T cell-mediated lysis independent of autophagy. Int J Oncol. 2017 May;50(5):1810-1820.24. Tie R Zhang T Yang B Fu H Han B Yu J Tan Y Huang H*. Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis. Oncotarget. 2017 Apr 18;8(16):27645-27660. 25. Piemontese S Ciceri F Labopin M Arcese W Kyrcz-Krzemien S Santarone S Huang H Beelen D Gorin NC Craddock C Gulbas Z Bacigalupo A Mohty M Nagler A. A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia.J Hematol Oncol. 2017 Jan 19;10(1):24.26. Han X Wang L Shi H Zheng G He J Wu W Shi J Wei G Zheng W Sun J Huang H Cai Z*. Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma. BMC Cancer. 2017 Jan 9;17(1):40. 27. Hu Y Wu Z Luo Y Shi J Yu J Pu C Liang Z Wei G Cui Q Sun J Jiang J Xie J Tan Y Ni W Tu J Wang J Jin A Zhang H Cai Z Xiao L Huang H*. Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia. Clin Cancer Res. 2017 Jul 1;23(13):3297-3306.28. Wang Y Wang Y Chang T Huang H* Yee JK. Integration-defective lentiviral vector mediates efficient gene editing through homology-directed repair in human embryonic stem cells. Nucleic Acids Res. 2017 Mar 17;45(5):e29.29. Hu Y Cui Q Ye Y Luo Y Tan Y Shi J  Huang H*. Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Hematol Oncol.2017 Mar;35(1):118-124. 30. Gu M Liu Z Lai R Liu S Lin W Ouyang C Ye S Huang H Wang X*. RKIP and TBK1 form a positive feedback loop to promote type I interferon production in innate immunity. EMBO J. 2016 Dec 1;35(23):2553-2565.31. Zhang M Fu H Lai X Tan Y Zheng W Shi J Zhao Y Lin M He J Cai Z Luo Y Huang H*. Minimal Residual Disease at First Achievement of Complete Remission Predicts Outcome in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia. PLoS One. 2016 Oct 3;11(10):e0163599.32. Sun J Hu J Huang Y Ying SW Han XY Zheng YL  Huang H*. Sorafenib-induced Thyroiditis in FMS-like Tyrosine Kinase 3-internal Tandem Duplication-mutated Acute Myeloid Leukemia. Chin Med J (Engl). 2016 Oct 20;129(20):2512-2513. 33. Xu Y Shan W Li X Wang B Liu S Wang Y Long Y Tie R Wang L Cai S Zhang H Lin Y Zhang M Zheng W Luo Y Yu X Yee JK Ji J Huang H*. A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells. J Hematol Oncol. 2016 Sep 29;9(1):102.34. Hu Y Sun J Wu Z Yu J Cui Q Pu C Liang B Luo Y Shi J Jin A Xiao L Huang H*. Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy. J Hematol Oncol. 2016 Aug 15;9(1):70. 35.  Zhu N Wang H Wei J Wang B Shan W Lai X Zhao Y Yu J Huang H*. NR2F2 regulates bone marrow-derived mesenchymal stem cell-promoted proliferation of Reh cells. Mol Med Rep. 2016 Aug;14(2):1351-6. 36. Liu L Yu Q Hu K Wang B Zhang Y Xu Y Fu S Yu X Huang H*. Electro-Acupuncture Promotes Endogenous Multipotential Mesenchymal Stem Cell Mobilization into the Peripheral Blood. Cell Physiol Biochem. 2016;38(4):1605-17.37. Luo C Wang J Hu Y Luo Y Tan Y Jin A Wei B Hu H Huang H*. Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature.Mycopathologia. 2016 Oct;181(9-10):753-8.38. Wu WJ Dong MM Chen Y He JS Huang H Cai Z*.Acute myeloid leukemia of a primary hepatic carcinoma patient after liver transplantation: a case report and literature review. Int J Clin Exp Pathol. 2015 .8(10):13655-60.39. Zhu N Wang H Wang B Wei J Shan W Feng J Huang H*.A Member of the Nuclear Receptor Superfamily Designated as NR2F2 Supports the Self-Renewal Capacity and Pluripotency of Human Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells Int. 2016:5687589. 40. Lin W Ma C Su F Jiang Y Lai R Zhang T Sun K Fan L Cai Z Li Z Huang H Li J Wang X*. Raf kinase inhibitor protein mediates intestinal epithelial cell apoptosis and promotes IBDs in humans and mice.Gut. 2017 Apr;66(4):597-610.41. Zhou M Zheng Y Ma S Zhou Li L Zhu J Zhu L Yang X Luo Y Huang H Ye X Xie W*. Clinical observation on hemogram variation of allogeneic donors from Chinese population for peripheral hematopoietic stem cells collection.Stem Cells Dev. 2016.25(10):798-802.42. Hu Y Cui Q Luo C Luo Y Shi J  Huang H*. A promising sword of tomorrow: Human γδ T cell strategies reconcile allo-HSCT complications. Blood Rev. 2016.30(3):179-188.43. Xiao H Wang LM Luo Y Lai X Li C Shi J Tan Y Fu S Wang Y Zhu N He J Zheng W Yu X Cai Z  Huang H*.  Mutations in epigenetic regulators are involved in acute lymphoblastic leukemia relapse following allogeneic hematopoietic cell transplantation. Oncotarget. 2016.7(3):2696-708.44. Long Y  Huang H*. On signaling pathways: hematopoietic stem cell specification from hemogenic endothelium. Sci China Life Sci. 2015.58(12):1256-61.45. Wang L Xiao H Zhang X Liao W Fu S  Huang H*.  Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells. Int J Oncol. 2015 Nov;47(5):1685-95.46. Zheng FL Shi JM Hu YX Zheng YL Cai Z Huang H*. The first case report of a patient with simultaneous haemophilia A and accelerated phase chronic myelogenous leukaemia. Haemophilia. 2015 Nov;21(6):e507-10.47. Shi JM Pei XY Luo Y Tan YM Tie RX He JS Zheng WY Zhang J Cai Z Lin MF  Huang H*. Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years.J Zhejiang Univ Sci B. 2015 Sep;16(9):796-804.48.    Hu K Gu Y Lou L Liu L Hu Y Wang B Luo Y Shi J Yu X Huang H*. Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.J Hematol Oncol. 2015 Jan 27;8(1):1.49. Gorin NC Labopin M Piemontese S Arcese W Santarone S Huang H Meloni G Ferrara F Beelen D Sanz M Bacigalupo A Ciceri F Mailhol A Nagler A Mohty M. T-cell-replete haploidentical transplantation versus autologous stem cell transplantation in adult acute leukemia: a matched pair analysis. Haematologica. 2015 Apr;100(4):558-64.50. Zhu N Xiao H Wang LM Fu S Zhao C Huang H*. Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies. Future Oncol. 2015 Feb;11(4):659-73.51. Ruggeri A Labopin M Sanz G Piemontese S Arcese W Bacigalupo A Blaise D Bosi A Huang H Karakasis D Koc Y Michallet M Picardi A Sanz J Santarone S Sengelov H Sierra J Vincent L Volt F Nagler A Gluckman E Ciceri F Rocha V Mohty M. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.Leukemia. 2015.29(9):1891-900.52. Wang B Hu Y Liu L Hu K Tie R He Y Fu S Zhu N Luo Y Yu X Huang H*. Phenotypical and Functional Characterization of Bone Marrow Mesenchymal Stem Cells in Patients with Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2015.21(6):1020-8.53. Wang X Wang Y Wu X Wang J Wang Y Qiu Z Chang T Huang H Lin RJ Yee JK. Nat Biotechnol. Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol. 2015 Feb;33(2):175-8.54. Piemontese S Ciceri F Labopin M Bacigalupo A Huang H Santarone S Gorin NC Koc Y Wu D Beelen D Tischer J Ehninger G Arcese W Nagler A Mohty M*. A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia. Leukemia. 2015.29(5):1069-75.55. Fu S Wei J Wang G Wang B Wang Y Lai X Huang H*. The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells. Int J Oncol. 2015. 46(1):351-9. 56. Zi FM He JS Li Y Wu C Yang L Yang Y Wang LJ He DH Zhao Y Wu WJ Zheng GF Han XY Huang H Yi Q Cai Z. Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in vitro and in xenograft models. Cancer Lett. 2015. 356(2 Pt B):443-53.57. Chen B Chen X Wu X Wang X Wang Y Lin TY Kurata J Wu J Vonderfecht S Sun G Huang H Yee JK Hu J Lin RJ. Disruption of microRNA-21 by TALEN leads to diminished cell transformation and increased expression of cell-environment interaction genes. Cancer Lett. 2015. 356(2 Pt B):506-16.58. Wang L Xiao H Zhang X Wang C Huang H*.The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation. J Hematol Oncol. 2014 Aug 20;7:61. 59. Gu M  Zhang T  Lin W  Liu Z  Lai R  Xia D  Huang H  Wang X*. Protein phosphatase PP1 negatively regulates the Toll-like receptor- and RIG-I-like receptor-triggered production of type I interferon by inhibiting IRF3 phosphorylation at serines 396 and 385 in macrophage. Cell Signal. 2014.26(12):2930-9. 60. Luo Y Xiao H Lai X Shi J Tan Y He J Xie W Zheng W Zhu Y Ye X Yu X Cai Z Lin M Huang H*. T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT.  Blood. 2014. 124(17):2735-43. 61. He Y Wu K Hu Y Sheng L Tie R Wang B Huang H*. γδ T cell and other immune cells crosstalk in cellular immunity. J Immunol Res. 2014:960252.62. Tan Y Du K Luo Y Shi J Cao L Zheng Y Zheng G Zhao Y Ye X Cai Z Huang H*. Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Transfusion. 2014 Jun;54(6):1493-500.63. Tie R Zhang T Fu H Wang L Wang Y He Y Wang B Zhu N Fu S Lai X Shi J Huang H*. Association between DNMT3A mutations and prognosis of adults with de novo acute myeloid leukemia: a systematic review and meta-analysis. PLoS One. 2014 Jun 17;9(6):e93353.64. He J Yang L Han X Zheng G Zheng W Wei G Wu W Ye X Shi J Xie W Li L Zhang J Huang W Zhao Y Huang H Zhang X Fu J Cai Z. The choice of regimens based on bortezomib for patients with newly diagnosed multiple myeloma. PLoS One. 2014 Jun 11;9(6):e99174.65. Zi FM He JS Li Y Wu C Wu WJ Yang Y Wang LJ He DH Yang L Zhao Y Zheng GF Han XY Huang H Yi Q Cai Z. Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway. Cancer Biol Ther. 2014 Jul 21;15(10).66. Chen WL Wang JH Zhao AH Xu X Wang YH Chen TL Li JM Mi JQ Zhu YM Liu YF Wang YY Jin J Huang H Wu DP Li Y Yan XJ Yan JS Li JY Wang S Huang XJ Wang BS Chen Z Chen SJ Jia W. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. Blood. 2014 Sep 4;124(10):1645-5467. Wu D Shao K Sun J Zhu F Ye B Liu T Shen Y Huang H Zhou Y. Matrine cooperates with all-trans retinoic acid on differentiation induction of all-trans retinoic acid-resistant acute promyelocytic leukemia Cells (NB4-LR1): possible mechanisms. Planta Med. 2014 Mar;80(5):399-408.68. Hu J Lei Y Wong WK Liu S Lee KC He X You W Zhou R Guo JT Chen X Peng X Sun H Huang H Zhao H Feng B. Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic Acids Res. 2014 Apr;42(7):4375-90.69. Wang X Wang Y Huang H Chen B Chen X Hu J Chang T Lin RJ Yee JK. Precise gene modification mediated by TALEN and single-stranded oligodeoxynucleotides in human cells. PLoS One. 2014 Apr 1;9(4):e93575.70. Zhang Y Hu K Hu Y Liu L Wang B Huang H*. Bone marrow mesenchymal stromal cells affect the cell cycle arrest effect of genotoxic agents on acute lymphocytic leukemia cells via p21 down-regulation. Ann Hematol. 2014 Sep;93(9):1499-508.71. Zhao Y Luo Y Shi J Cai Z Huang H*. Second-generation tyrosine kinase inhibitors combined with stem cell transplantation in patients with imatinib-refractory chronic myeloid leukemia. Am J Med Sci. 2014 Jun;347(6):439-45.72. Wang Y Zhao Y Liu L Zhang L Xiao H Wu K Xu Y Hu Y Fu H Cao W Luo Y Huang H*. Inhibitory effects of imatinib mesylate on human epidermal melanocytes. Clin Exp Dermatol. 2014 Mar;39(2):202-8.73. Jiang Y Hu K Xie W Zheng G Sun J Zheng Y Huang H*. Hyperthyroidism with  concurrent FMS-like tyrosine kinase 3-internal tandem duplication- positive acute  promyelocytic leukemia: A case report and review of the literature. Oncol Lett. 2014 Feb;7(2):419-422.74. Wu K Zhao Y He Y Wang B Du K Fu S Hu K Zhang L Liu L Hu Y Wang Y  Huang H*. Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathways.Leuk Lymphoma. 55(3):668-676. 2014.75. Wu K Wang Y He Y Hu Y Fu H Sheng L Wang B Fu S  Huang H*. Dasatinib promotes the potential of proliferation and antitumor responses of human γδT cells in a long-term induction ex vivo environment.Leukemia. 28(1):206-210. 2014.76. Gu Y Hu Y Hu K Liao W Zheng F Yu X Huang H*. Rapamycin together with TGF-β1 IL-2 and IL-15 induces the generation of functional regulatory γδT cells from human peripheral blood mononuclear cells. J Immunol Methods. 402(1-2):82-87. 2014.77. Xiao H Luo Y Lai X Shi J Tan Y He J Xie W Zheng W Ye X Yu X Cai Z Lin M Huang H*. Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes. Bone Marrow Transplant. 49(2):241-247. 2014.78. Sun J Fu S Zhong W Huang H*. PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells. Oncol Rep. 30(6):2785-94. 2013.79. Jiang Y Xie W Hu K Sun J Zhu X Huang H*. An aggressive form of non-Hodgkins lymphoma with pleural and abdominal chylous effusions: A case report and review of the literature. Oncol Lett. 6(4):1120-1122. 2013.80. Zhu X Lai X Luo Y Shi J Tan Y Zheng W He J Xie W Li L Zhang J Ye X Lin M Cai Z Huang H*.Combination of low-dose mycophenolate mofetil with cyclosporine and methotrexate as GVHD prophylaxis in unrelated donor allogeneic stem cell transplantation. Leuk Res . 37(9): 1046-51. 2013.81. Sheng L Fu S Hu Y Fu H Huang H*. Rapid mobilization of fully functional natural killer cells into blood by AMD3100. Transfusion. 53(9):2108-1010. 2013.82. Hu Y Cui Q Gu Y Sheng L Wu K Shi J Tan Y Fu H Liu L Fu S Yu X  Huang H*. Decitabine facilitates the generation and immunosuppressive function of regulatory gammadeltaT cells derived from human peripheral blood mononuclear cells. Leukemia. 27(7): 1580-1585. 2013. 83. Xie W Zhou D Hu K Xiao X Huang W He J Shi J Luo Y Zhang J Lin M Cai Z Huang H Ye X*. Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy. Exp Ther Med. 6(1):109-114. 2013.84. Zhao Y Huang H Wei G*. Novel agents and biomarkers for acute lymphoid leukemia. J Hematol Oncol. 6:40. 2013.85. Zhang L Zheng W Wang Y Wang Y Huang H*. Human bone marrow mesenchymal stem cells support the derivation and propagation of human induced pluripotent stem cells in culture. Cell Reprogram. 15(3):216-223. 2013.86. Zhou D Xie W Hu K Huang W Wei G He J Shi J Luo Y Li L Zhu J Zhang J Lin M Ye X Cai Z Huang H*. Prognostic values of various clinical factors and genetic subtypes for diffuse large B-cell lymphoma patients: a retrospective analysis of 227 cases. Asian Pac J Cancer Prev. 14(2):929-34. 2013.87. Du K Hu Y Wu K Huang H*. Long-term outcomes of antithymocyte globulin in patients with hematological malignancies undergoing myeloablative allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis. Clin Transplant. 27(2):E91-E100. 2013.88. Zheng W Wang Y Chang T Huang H*. and Yee JK*. Significant differences in genotoxicity induced by retrovirus integration in human T cells and induced pluripotent stem cells. Gene. 519(1):142-9. 2013.89. Xie W Hu K Xu F Zhou D He J Shi J Luo Y Zhu J Zhang J Lin M Ye X Huang H Cai Z*. Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma. Ann Hematol. 92(4): 481-486. 2013.90. Shi J Meng X Luo Y Tan Y Zhu X Zheng G He J Zheng WY Xie W Li L Ye X Zhang J Cai Z Lin M Huang H*.  Clinical characteristics and outcome of isolated extramedullary relapse in acute leukemia after allogeneic stem cell transplantation: a single-center analysis. Leuk Res . 37(4):372-7.2013.91. He J Zhu L Ye X Li L Zhu J Zhang J Xie W Shi J Zheng W Wei G Sun J CaiZ Huang H*.  Clinical Characteristics and Prognosis of 23 Patients With Nonleukemic Myeloid Sarcoma. Am J Med Sci. 2014 Jun;347(6):434-8.92. Wang C Xiao H Ma J Zhu Y Yu J Sun L Sun H Liu Y Jin C Huang H*.  The F-box protein beta-TrCP promotes ubiquitination of TRF1 and regulates the ALT-associated PML bodies formation in U2OS cells. Biochem Biophys Res Commun. 434(4):728-34. 2013.93. Xie W Zhao Y Cao L Huang W Wang Y Huang H*. Cutaneous blastic plasmacytoid dendritic cell neoplasm occurring after spontaneous remission of acute myeloid leukemia: a case report and review of literature.Med Oncol. 29(4):2417-22. 2012.94. Xiao H Luo Y Lai X Fu S Shi J Tan Y He J Xie W Zheng W Wang L Zhang L Liu L Ye X Yu X Cai Z Lin M Huang H*. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. Haematologica. 97 (12):1804-1812. 2012.95. Hu Y Gu Y Cui Q Fu H Sheng L Wu K Liu L Fu S Yu X Huang H*. Phytohemagglutinin - activated human T cells induce lethal graft-versus-host disease in cyclophosphamide and anti - CD122 conditioned NOD/SCID mice. Ann Hematol . 91 (11): 1803-1822. 2012.96. Zhu Y Wang C Lan J Yu J Jin C. & Huang H*. Phosphorylation of Tara by Plk1 is essential for faithful chromosome segregation in mitosis. Exp Cell Res. 318 (18) 2344-2352. 2012.97. Liu L Hu K Wang B Huang H*. Yu Q. Mobilization of endogenous stem cells: A new strategy for bone healing. Bone. 51 (3): 633-634. 2012.98. Wu W Cao L Li Y Yu X Huang H He J*. Primary splenic diffuse large B-cell lymphoma in a patient with thymus Rosai-Dorfman disease. Am J Med Sci. 344(2):155-9. 2012.99. Wu K Luo Y Liu L Zhao Y Hu Y Tan Y Lai X  Huang H*. Twin pregnancy and childbirth after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation combined with imatinib mesylate for chronic myeloid leukaemia: case report and literature review. J Int Med Res . 40:2409-15. 2012.100.Wang T Huang H，CH Tzeng Wang P Wu T Sun J Tang J Hu J Lin S Kao R*. Impact of donor characteristics and HLA matching on survival of chinese patients with hematologic malignancies undergoing unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant .18:1939-44. 2012.101.Huang X Chen H Han M Zou P Wu D Lai Y Huang H Chen X Liu T Zhu H Wang J Hu J*. Multicenter randomized open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant. Biol Blood Marrow Transplant 18:1509-16. 2012.102.Xu Y Liu L Zhang L Fu S Hu Y Wang Y Fu H Wu K Xiao H Liu S Yu X Zheng W Feng B Huang H*. Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells. PLoS One 7(4): e34321. 2012.103.  Zhang L Wang Y Huang H*. Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review. Clin Transplant. 26 (4): 511-519. 2012.104. Sun J Wang Z Luo Y Tan Y David S.Allan Huang H*. Prolonged survival with imatinib mesylate combined with chemotherapy and allogeneic stem cell transplantation in de novo Ph+ acute myeloid leukemia. Acta Haematol. 127:143-148. 2012.105.Xu Y Liu L Zhang L Fu S Li R Hu K and Huang H*.Efficient generation of induced pluripotent stem cells from human bone marrow mesenchymal stem cells. Folia Biol (Praha) . 58(6):221-30. 2012.106.Cao W Xiao H Lai X Luo Y Shi J Tan Y Zheng W He J Xie W Li L Ye X Yu X Lin M Cai Z Huang H*. Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation. Biol Blood Marrow Transplant. 18(2): 273-279. 2012.107.  Hu Y LuoY Tan Y Shi J Sheng L Fu H Liu L Xu Y Wu K Xiao H Zhang L Yu X Cai Z Huang H*. Donor bone marrow-derived stem cells contribute to oral squamous cell carcinoma transformation in a recipient after hematopoietic stem cell transplantation. Stem Cells Dev. 21: 177-180. 2012.108.Chang T Zheng W Tsark W Bates S Huang H Lin R Yee JK*.  Phenotypic rescue of Induced pluripotent stem cell-derived motoneurons of a spinal muscular atrophy patient. Stem Cells. 29: 2090-2093. 2011.109.  Wei G Ni W Chiao J Cai Z Huang H， Liu D*. A meta-analysis of CAG (cytarabine aclarubicin G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome. J Hematol Oncol 4: 46. 2011.110.Liu L Wang Y Wu K Fu S Zhang L Xu Y Huang H*. The tyrosine kinase inhibitor nilotinib inhibits proliferation and osteoblast differentiation of human mesenchymal stromal cells. Bone. 49(5):1117-1118. 2011.111.Liu L Yu Q Lin J Lai X Cao W Du K Wang Y Wu K Hu Y Zhang L Xiao H Duan Y Huang H*. Hypoxia-inducible factor-1α is essential for hypoxia-induced mesenchymal stem cell mobilization into the peripheral blood. Stem Cells Dev. 20(11):1961-71. 2011. 112.Luo Y Zhao Y Tan Y Shi J Han X Zheng Y Li L He J Xie W Ye X Cai Z Lin M Huang H*. Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia. Leu Res. 35: 1307-1311. 2011.113.Zhao Y Tan Y Wu G Liu L Wang Y Luo Y Shi J Huang H*. Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloid leukemia. Int J Hematol. 94: 156-162. 2011.114.Hu Y Cui Q Liang BHuang H* Relapsing hematologic malignancies after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 17(8): 1099-1111. 2011.115.Xiao H Shi J Luo Y Tan Y He J Xie W Zhang L Wang Y Liu L Wu K Yu X  Cai Z Lin M Ye X Huang H*. First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood. 117(19): 5257-5260. 2011.116.Tan Y Fu H Luo Y Shi J Ye X Zheng Y Xiao H Hu Y Huang H*. Haploidentical Allogeneic Haematopoietic Stem Cell Transplantation as Salvage Therapy for Engraftment Failure after Unrelated and Autologous Stem Cell Transplantation: a Case Report and Review of the Literature. J Int Med Res. 39: 950-959. 2011.117.Xiao H Cao W Lai X Luo Y Shi J Tan Y He J Xie W Meng X Zheng W Zheng G Han X Jin L Zhang L Wang Y Yu X Cai Z Lin M Ye X Huang H*. Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in Chinese population. Biol Blood Marrow Transplant. 17: 542-549. 2011.118.Xiao H Lai X LuoY Shi J Tan Y He J Xie W Li L Zhu X Zhu J Sun J Wei G，Jin L，Liu L，Wu K，Yu X Cai Z Lin M Ye X Huang H*. Relationship between TNFA TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in Chinese population. Bone Marrow Transplant. 46: 400-407. 2011.119.Mou H Lin M Huang H Cai Z*. Transforming growth factor-beta1 modulates lipopolysaccharide-induced cytokine/chemokine production and inhibits nuclear factor-kappaB extracellular signal-regulated kinases and p38 activation in dendritic cells in mice. Transplant Proc. 2011. 43(5):2049-2052.120.Wang C Yu J Yuan K Lan J Jin C* Huang H*.  Plk1-mediated phosphorylation of PinX1 regulates its stability. Eur J Cell Biol. 89(10): 748-756. 2010.121.Hu Y Cui Q Liang B Huang H*. Donor-derived solid malignancies after hematopoietic stem cell transplantation. Onkologie. 33(4):195-200. 2010.122.Wu G Zhao Y Lai X Luo Y Tan Y Shi J Li L Zheng W Zhang J Hu X Jin A He J Xie W Ye X Cai Z Lin M Huang H*. The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population. Bone Marrow Transplant. 45: 1514-1521. 2010.123.Zheng W Guan M Zhu L Cai Z Chung V Huang H*， Yen Y. Bortezomib therapeutic effect is associated with expression and mutation of FGFR3 in human lymphoma cells. Anticancer Res. 30(6): 1921-1930. 2010.124.Dong-Wook Kim* Shripad D. Banavali Udomsak Bunworasate Yeow-Tee Goh Peter Ganly Huang H Ian Irving Saengsuree Jootar Hyun-Gyung Goh Liang-Piu Koh Wei Li Tomoki Naoe Soo-Chin Ng Visalachy Purushotaman Harryanto Reksodiputro Lee-Yung Shih Jih-Luh Tang Arinobu Tojo Jianmin Wang Raymond Wong. Chronic myeloid leukemia in the Asia-Pacific region: current practice challenges and opportunities in the targeted therapy era. Leuk Res. 34(11): 1459-1471. 2010.125.Yu J Lan J Wang C Wu Q Zhu Y Lai X Sun J Jin C* Huang H*. PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells. Cancer Lett. 291(2): 177-186. 2010.126.Wu G Zhao Y Lai X Yang K Zhu F Zhang W Wang W Luo Y Tan Y Wang Y Cao W Huang H*. Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations. Tissue Antigens. 74(6): 499-507. 2009.127.Wu Q Hu H Lan J Emenari C Wang Z Chang K Huang H Yao X*. PML3 Orchestrates the Nuclear Dynamics and Function of TIP60. J Biol Chem. 284(13):8747-8759. 2009.128.Luo Y Lai X Tan Y Shi J Zhao Y Han X Zheng G Zhu X Sun J Zheng Y Wu G He J Chen S Jin A Xie W Ye X Cai Z Lin M Huang H*. Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase. Leukemia. 23(6):1171-1174. 2009.129.Zhao Y Liu L Wang Y Wu G Lai X Cao W Luo Y Tan Y Shi J Xie W Ye X Cai Z Lin M Huang H*. Efficacy and Prognosis of Chronic Myeloid Leukemia Treated With Imatinib Mesylate in a Chinese Population. Int J Hematol. 89(4):445-451. 2009.130.Zhao Y Wu G Wu K Liu L Cao W Yu X Luo Y Shi J Tan Y Huang H*.  Simultaneous occurrence of variant Philadelphia translocations and ABL mutations in two patients with chronic myeloid leukemia. Leuk Res. 33(7):e85-87. 2009.131.Zheng W Wei G Ye X He J Li L Wu W Shi J Zhang J Huang W Xie W Luo Y Xue X Lin M Huang H Cai Z*. Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience. Leuk Res. 33(12):1615-1618. 2009.132.Qiu L He J* Ye X Xie W Shi J Zheng W Sun J Zhu X Cai Z Huang H Lin M. Invasive pulmonary fungal infection accompanied by severe hemoptysis in patients with hematologic diseases: a report of nine cases. Int J Hematol. 90(1):108-112. 2009.133.Shi J Cai Z* Huang H Ye X He J Xie W Zhang J Zhou X Luo Y Lin Y Li L Zheng W Wei G Lin M. Role of CT-guided percutaneous lung biopsy in diagnosis of pulmonary fungal infection in patients with hematologic diseases. Int J Hematol. 89(5):624-627. 2009.134.Yu J Lan J Zhu Y Li X Lai X Xue Y Jin C* Huang H*. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara. Biochem Biophys Res Commun. 367(4):805-812. Mar 2008.135.Zhao YM Li JY Lan JP Lai XY Luo Y Sun J Yu J Zhu YY Zeng FF Zhou Q Huang H*. Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 369(4): 1114-1119. May 2008.136.Zhao YM Zhou Q Xu Y Lai XY Huang H*. Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition. Acta Pharmacol Sin. 29(4):481-488. Apr 2008.137.Cheng Z Ke Y Ding X Wang F Wang H Wang W Ahmed K Liu Z Xu Y Aikhionbare F Yan H Liu J Xue Y Yu J Powell M Liang S Wu Q Reddy SE Hu R Huang H Jin C Yao X*. Functional characterization of TIP60 sumoylation in UV-irradiated DNA damage response. Oncogene. 27(7): 931-941. Feb 2008.138.Luo Y Zhang A Huang H* Zheng S. Haemolytic uraemic syndrome after living-donor liver transplantation：is small-for-size graft a potential risk factor?J Int Med Res. 36(3):599-604. May-Jun 2008.139.Li X Lan J Zhu Y Yu J Dou Z Huang H*. Expression purification and characterization of Tara a novel telomere repeat-binding factor 1 (TRF1)-binding protein. Protein Expr Purif. 55(1):84-92. Sep 2007.140.Sun J Huang H* Zhu Y Lan J Li J Lai X Yu J. The expression of telomeric proteins and their probable regulation of telomerase during the differentiation of all-trans-retinoic acid-responsive and -resistant acute promyelocytic leukemia cells. Int J Hematol. 82(3):215-222. Oct 2005.141.Fu C Ahmed K Ding H Ding X Lan J Yang Z Miao Y Zhu Y Shi Y Zhu J Huang H* Yao X*. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene. 24(35): 5401-5413. Aug 2005.出版著作:内科学进展（第二版）， 20040900感染微生态学，20021010全科医学临床治疗学，20020301临床疾病与免疫，20020110内科学新进展，20001210研究与探索，19990201学术交流（讲座报告）:在国际大型会议担任主席、特邀报告和口头报告：1. Huang H*. The report of transplantation in China in five recent year. (第22届亚太地区骨髓移植会议）（特邀报告）(October 28-30 2017 Tehran Iran).2. Huang H*. Advanced CD19-CART therapy for acute lymphocytic leukemia and B cell lymohoma/ China Perspective. (第22届亚太地区骨髓移植会议）（特邀报告）(October 28-30 2017 Tehran Iran).3. Huang H*. Haploidentical hematological stem cell transplantation as a front line therapy for adult Acute Lymphocytic Leukemia.  (第22届亚太地区骨髓移植会议）（特邀报告）(October 28-30 2017 Tehran Iran).4. Huang H*. Management of CD19-targeted CAR-T Associated Complications. 43th Annual Meeting of the European Group for Blood and Marrow Transplantation2017.3.26-3.29 Marseille France（特邀报告）.5. Huang H*. CAR-T cells post allo-transplant: practical considerations. The winter workshop of 43th Annual Meeting of the European Group for Blood and Marrow Transplantation. November 26 2016 Marseille France. （特邀报告）6. Huang H*. Emerging Cellular Therapies-CART cell in Hematological malignant disease. The 21th Congress of Asia-Pacific Blood and Marrow Transplantation. (第21届亚太地区骨髓移植会议）（特邀报告）(October 28-30 2016 Singapore).7. Hu Y  Huang H*. Superiior therapeutic efficacy of CART19 over chemotherapy in relapsed/refractory ALL patients. 21th Congress of the Asia-Pacific Blood and Marrow Transplantation. (第21届亚太地区骨髓移植会议）（口头报告）(October 28-30 2016 Singapore).8. Wang B Shan W Liu S Lin Y Zhang H Zhu N   Cai S   Yu X  Huang H*. TSC-mTOR Signaling Pathway Regulates the Immunogenicity of Bone Marrow Mesenchymal Stem Cells in Inflammatory Microenvironment. Bone Marrow Transplant. 51(suppl 1): S64. 42th Annual Meeting of the European Group for Blood and Marrow Transplantation 2016.4.3-4.6 Valencia SPAIN. 第42届欧洲血液与骨髓移植年会，口头报告9. Hu Y  Wu Z  Luo Y  Shi J Pu C  Wei G  Sun J  Yu J Xiao L Huang H*. Safety and Efficacy of CD19 Chimeric Antigen Receptor-Modified T Cells for Relapsed/Refractory Acute Lymphocytic Leukemia Under Fludarabine and Cyclophosphamide based Lymphodepletion. Bone Marrow Transplant. 51(suppl 1): S99-100. 42th Annual Meeting of the European Group for Blood and Marrow Transplantation 2016.4.3-4.6 Valencia SPAIN. 第42届欧洲血液与骨髓移植年会，口头报告10. Huang H*. Current States of Stem Cell Transplantation in China.Catholic .2015中韩慢粒研讨会 2015.3.27 Seoul Korea 特邀报告11. Huang H*. Biological Advances in Leukemia Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation. 第19届亚太地区骨髓移植会议 2014.11.16-19 Hangzhou China 特邀报告12. Sheng L Fu H Hu Y Luo Y Lai X Tan Y Shi J Fu S He Y Huang H*.Impaired NK cells cytotoxicity against activated alloreactive donor T cells in aGVHD can be corrected by dasatnib ex vivo. 第19届亚太地区骨髓移植会议 2014.11.16-19 Hangzhou China 口头报告13. Xiao H Luo Y Wang L-M Lai X Shi J Tan Y Fu S Wang Y He J Xie W Zheng W Ye X Yu X Cai Z Lin M Huang H*. Exome Sequencing of Adult Philadephia Chromosome-Negative Acute Lymphoblastic Leukemia from Diagnosis to Relapse after Allogeneic Hematopoietic Cell Transplantation Reveals Novol Mutated Genes and Clonal Evolution. 第19届亚太地区骨髓移植会议 2014.11.16-19 Hangzhou China 口头报告14. Luo Y Xiao H Lai X Shi J Tan Y He J Xie W Zheng W Zhu Y Ye X Cai Z Lin M and Huang H*. Prospective evaluation of T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with contemporaneous matched sibling HSCT and unrelated HSCT: results from an open-label trial. 第40届欧洲血液与骨髓移植年会 2014.3.30-4.2 Milan Italy 口头报告15. Xiao H Huang H*. Genomic Evolution and Genetic Alterations in Adult Patients with Philadephia Chromosome-negative Acute Lymphoblastic Leukemia from Diagnosis to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. 第40届欧洲血液与骨髓移植年会 2014.3.30-4.2 Milan Italy 口头报告16. Wang Y Zhang L Liu S Huang H*. Defining Molecular Roadblocks through an Intermediate Standstill Derived during Reprogramming Human Fibroblast to iPS Cell. 第40届欧洲血液与骨髓移植年会 2014.3.30-4.2 Milan Italy 口头报告17. Hu K Gu Y Lou L Liu L Hu Y Fu S Wang B Yu X Huang H*. Bone marrow mesenchymal stromal cells protect acute leukemia cells from cytotoxic agents via galectin-3 mediated Wnt/β-catenin signaling. 第40届欧洲血液与骨髓移植年会 2014.3.30-4.2 Milan Italy 口头报告18. Xiao H Luo Y Lai X Shi J Tan Y He J Xie W Zheng W Wang L Fu S Wang Y Ye X Yu X Cai Z and Huang H*. Whole-exome Sequencing of Adult Philadephia-negative Acute Lymphoblastic Leukemia from Diagnosis to Relapse after Allogeneic Hematopoietic Stem Cell Transplantation Reveals Clonal Evolution and Relapse-associated Mutated Genes. Blood.2013.122:156. 第55届美国血液学年会 2013.12.7-10 New Orleans USA 口头报告         19. Zhang M Luo Y Lai X Tan Y Zheng W Zhu Y Shi J and Huang H*. Minimal residual disease levels at time of CR1 and transplant predict outcome in Philadephia chromosome-negative adult ALL. Blood.2013.122:713. 第55届美国血液学年会 2013.12.7-10 New Orleans USA 口头报告20. Huang H*. Biology Prevention and Treatment of Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation. 第18届亚太地区骨髓移植会议 2013.11.1-4 Ho Chi Ming City Vietnam 特邀报告21. Du K Huang H*. A signal center analysis of Philadephia chromosome-positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in imatinib era. 第18届亚太地区骨髓移植会议 2013.11.1-4 Ho Chi Ming City Vietnam 口头报告22. Shi J Huang H*. Epidemiology of invasive fungal infections in allogeneic stem cell transplantation recipients: risk factors for infection according to time after transplantation. 第18届亚太地区骨髓移植会议 2013.11.1-4 Ho Chi Ming City Vietnam 口头报告23. Hu Y Huang H*. Reduced frequency of FOXP3+ gammadeta TCR+ regulatory T cells in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. 第18届亚太地区骨髓移植会议 2013.11.1-4 Ho Chi Ming City Vietnam 口头报告24. Tan Y Huang H*.Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients post allogeneic hematopoietic stem cell transplantation. 第18届亚太地区骨髓移植会议 2013.11.1-4 Ho Chi Ming City Vietnam 口头报告25. Hu Y Luo Y Shi J Tan Y Zheng W Cai Z Huang H*.HBsAg- recipients had comparable outcomes and acquired HBV-specific humoral immunity after haematopoietic stem cell transplantation from HBsAg+ donors. Bone Marrow Transplant. 48(suppl 2): S29.第39届欧洲血液与骨髓移植年会 2013.4.7-10 London UK 口头报告26. Xiao H Luo Y Lai X Fu S Shi J Tan Y He J Xie W Zheng W Wang L ZhangL Liu L Ye X Yu X Cai Z Lin M Huang H*.Genetic variations in graft-versus-leukemia reaction pathways and relapse risk after allogeneic hematopoietic stem cell Transplantation: an explore study. 美国国立卫生研究院第二届国际造血干细胞移植后复发工作会议 2012.11.5-6 Washington USA 口头报告27. Huang H*. Allogeneic transplantation in AML-CR1 in era of molecular markers. 第17届亚太地区骨髓移植会议 2012.10.26-28 Hyderabad India 特邀报告28. Xiao H Luo Y Lai X Fu S Shi J Tan Y He J Xie W Zheng W Wang L Zhang L Liu L Ye X Yu X Cai Z Lin M Huang H*Genetic variations in Toll-like receptors and acute GVHD in allogeneic hematopoietic stem cell transplantation. 第17届亚太地区骨髓移植会议 2012.10.26-28 Hyderabad India 口头报告 29. Hu Y Gu Y Wu K Sheng L Huang H*.Factors affecting human T cell engraftment trafficking and associated xenogeneic graft-versus-host disease in cyclophosphamide and anti-CD122 conditioned NOD/SCID mice. 第17届亚太地区骨髓移植会议 2012.10.26-28 Hyderabad India 口头报告30. Xiao H Luo Y Lai X Fu S Shi J Tan Y He J Xie W Zheng W Wang L Zhang L Liu L Ye X Yu X Cai Z Lin M Huang H*. Persistent cytomegalovirus reactivation and cytomegalovirus UL97 mutations in the seropositive haematopoietic stem cell transplantation setting. Bone Marrow Transplant. 47(suppl 2): S25.第38届欧洲血液与骨髓移植年会 2012.4.1-4 Geneva Switzerland 口头报告31. Hu Y Gu Y Sheng L Wu K Shi J Tan Y Yu X and Huang H *. Decitabine -conditioned regulatory gamma delta T Cells provide enhanced protection from graft-versus-host disease via improved Foxp3 stability and ICOS up-regulation. Bone Marrow Transplant. 47(suppl 2): S72. 第38届欧洲血液与骨髓移植年会 2012.4.1-4 Geneva Switzerland 口头报告32. Wu KN Hu YX Fu HR Sheng LX and Huang H*. Ex Vivo-Expanded gamma deltaT Cells Can Efficiently Kill Human Acute Myeloid Leukemia Cells Via Trogocytosis. Blood.2011.118: 580. 第53届美国血液学年会 2011.12.10-13 San Diego USA 口头报告         33. Huang H*. Biological advances and intervention in leukemia relapse following allogeneic hematopoietic stem cell transplantation. 第16届亚太地区骨髓移植会议 2011.10.30-11.2 Sydney Australia 特邀报告34. Xiao H Luo Y Shi J Tan Y He J Xie W Lai X Yu X Cai Z Lin M Ye XHuang H*. Donor Natural Killer Cell Activating Gene Polymorphisms Associated with the Risk of Early Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation. 第16届亚太地区骨髓移植会议 2011.10.30-11.2 Sydney Australia 口头报告35. Huang H*. Plasma Proteins: New Biomarkers in the Diagnosis and Treatment of   Complications of Allogeneic Hematopoietic Stem Cell Transplantat. 第7届中日生命科学研讨会 2011.11.23-24 Kumamoto Japan 特邀报告36. Xu Y Huang H*. Induction of Hematopoietic Commitment from Adult Human Bone Marrow Mesenchymal Stem Cell-derived Induced Pluripotent Stem Cells with Cytokines. 第16届亚太地区骨髓移植会议 2011.10.30-11.2 Sydney Australia 口头报告37. Xiao H Luo Y Shi J Tan Y He J Xie W Lai X Yu X Cai Z Lin M Ye XHuang H*. Donor selection for natural killer cell activating genes leads to a reduced rate of relapse after allogeneic hematopoietic cell transplantation both for acute myeloid leukemia and acute lymphoblastic leukemia. Bone Marrow Transplant. 46(suppl 2): S73.第37届欧洲血液与骨髓移植年会 2011.4.3-6 Paris France 口头报告38. Xiao H Luo Y Shi J Tan Y He J Xie W Lai X Yu X Cai Z Lin M Ye XHuang H*. Association between genetic variants in T-cell costimulatory molecule and outcome after unrelated hematopoietic cell transplantation. Bone Marrow Transplant. 46(suppl 2): S18.第37届欧洲血液与骨髓移植年会 2011.4.3-6 Paris France 口头报告39. Xiao H Lai X Luo Y Shi J Tan Y He J Xie W Zhang L Wang Y Cai Z Lin MYe X Huang H*.T-cell costimulatory molecule genotypes are associated with the risk of early cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation. 2011.17(2)(suppl 2):S156. 2011年美国血液学会骨髓移植年会 2011.2.17-21 Honolulu USA 口头报告40. Xiao H Lai X Luo Y Shi J Tan Y He J Xie W Zhang L Wang Y Cai Z Lin M Ye X and Huang H*. The Genotype of T-cell Costimulatory Molecule is Associated with Relapse Incidence in Patients with Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation. Blood.2010; 116(21): 301 第52届美国血液学年会 2010.12.4-7 Orlando USA 口头报告         41. Huang H*. Recent advances and choices of transplantation conditioning regimen.第15届亚太地区骨髓移植会议 2010.10.28-31 Phuket Thailand 主席 特邀报告42. Xiao H Zhu X Cao W Lai X Luo Y Shi J Tan Y He J Xie W Zhang L WangY Cai Z Lin M Ye X and Huang H*. Effect of low-dose short-course mycophenolate mofetil as GVHD prophylaxis and study of the polymorphisms of target gene of mycophenolate mofetil. 第15届亚太地区骨髓移植会议 2010.10.28-31 Phuket Thailand 口头报告 口头报告二等奖43. Xiao H Lai X Luo Y Shi J Tan Y He J Xie W Meng X Zheng G Han X Yu XCai Z Lin M Ye X Huang H*.Donor and recipient TGF-beta 1 gene polymorphisms are associated with the risk of early cytomegalovirus infection after allogeneic stem cell transplantation. Bone Marrow Transplant. 45(suppl 2): S37.第36届欧洲血液与骨髓移植年会 2010.3.21-24 Vienna Austria 口头报告44. Huang H*. New advances in the research of graft-versus-host disease after allo-HSCT. 2010年台湾血液学年会 2010.4.9 Taiwan 特邀报告45. Huang H*. Cross-Straits Summit in Managing Acute Leukemia: Challenges and Options in 2010 and Beyond. 2010年台湾血液学年会 2010.4.9 Taiwan 主席46. Huang H*. Reduced intensity transplantation: current role and future prospects. 第一届东亚血液学联盟会议 2010.4.22-24 Kuala Lumpur Malaysi 特邀报告47. Huang H*. Transplantation in autoimmune disease. 第一届东亚血液学联盟会议 2010.4.22-24 Kuala Lumpur Malaysi 特邀报告48. Huang H*. China consensus of CML treatment 2010. 2010年亚太慢性粒细胞白血病顾问委员会会议 2010.4.25 Kuala Lumpur Malaysi 特邀报告49. Huang H*. Advance of mesenchymal stem cell research and application in clinic.第4届西澳分子与细胞治疗论坛 2010.4.26-5.7 The University of Western Australia 特邀报告50. Huang H*. Prophylaxis and treatment of graft-versus-host disease following allo-HSCT. 第14届亚太地区骨髓移植会议 2009.8.27-29 Seoul Korea 主席 特邀报告51. Xiao H Lai X Luo Y Shi J Tan Y He J Xie W Meng X Zheng G Han X Yu X Cai Z Lin M Ye X Huang H*Association between tumor necrosis factor-α gene polymorphisms and acute graft-versus-host disease in unrelated donor allogeneic haematopoietic stem cell transplantation in Chinese population. 第14届亚太地区骨髓移植会议 2009.8.27-29 Seoul Korea 口头报告52. Lai X Huang H* Huang L Cao J Zeng F Zheng J. Identification and enrichment of human bone marrow derived mesenchymal stem cells by monoclonal antibody ZUC3. Bone Marrow Transplant. 41(suppl.1):S16. 第34届欧洲血液与骨髓移植年会 2008.3.30-4.2 Flroence Italy 口头报告53. Huang H* Fan J Lai X Yu Q Ding W Wang Y. Intracerebral transplantation of human mesenchymal stem cells after hypoxic-ischemic brain damage in rat. Bone Marrow Transplant. 41(suppl.1):S16.第34届欧洲血液与骨髓移植年会 2008.330-4.2 Flroence Italy 口头报告54. Huang H*. Allogeneic Transplantation for Acute Lymphoblastic Leukemia. 2007年美国血液肿瘤治疗进展研讨会 New York USA 特邀报告55. Huang H*. Treatment Strategies for Adult Acute Lymphoblastic Leukemia: Unrelated Donor Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in First Complete Remission. 第12届亚太地区骨髓移植会议 2007.9 Beijing China 特邀报告56. Huang H*. Unrelated Donor Hematopoietic Stem Cell Transplantation for 128 Patients with Hematological Malignancy. 第11届亚太地区骨髓移植会议 2006.10 Nagoya Japan 口头报告57. Huang H*. Unrelated Donor Hematopoietic Stem Cell Transplantation for Leukemia and Myelodysplastic Syndrome. 2006年亚太骨髓捐献者登记组织会议 2006.4 Taiwan 特邀报告58. Huang H*. Unrelated Donor Hematopoietic Stem Cell Transplantation for Leukemia and Myelodysplastic Syndrome. 第10届亚太地区骨髓移植会议 2005.10 Hangzhou China 特邀报告专利成果:1.   黄河，徐玉林，于晓虹，一种利用三维诱导系统获得造血干细胞的方法，2017年  12月1日，中国，201410170829.6。2.    黄河，顾嫣珺，胡永仙，雷帕霉素诱导调节性γδT细胞的培养方法，2016年2月3日，中国，ZL201310384046.3。3.    黄河，胡永仙，吴康妮，一种调节性T细胞的诱导培养方法，2012年08月29日，中国，ZL201110035687.9。4.    黄河，胡永仙，顾嫣君，谭亚敏，一种NOD/SCID小鼠异种移植物抗宿主病模型的建立方法，2013年7月10日，中国，ZL201210005931.1。5.    黄河，徐玉林，刘丽珍，一种获得诱导多能干细胞的方法，2012年10月17日，中国，ZL201110261281.2。6.    黄河，徐玉林，刘丽珍，一种获得造血干细胞的方法，2013年7月31日，中国，ZL201110300957.4。7.    黄河，张丽飞，郑伟燕，用人间充质干细胞滋养层培养诱导多能干细胞的方法，2013年7月31日，中国，ZL201110036898.4。8.    黄河，来晓瑜，沈建根，单抗ZUB1 免疫磁珠分选原代人骨髓间充质干细胞的方法，2009 年10 月28 日，中国，ZL200610050760.9。9.    黄河，来晓瑜，沈建根，单抗ZUC3 免疫磁珠分选原代人骨髓间充质干细胞的方法，2009 年10 月28日，中国，ZL200610050761.3。10.  黄河，来晓瑜，沈建根，单抗ZUB4 免疫磁珠分选原代人骨髓间充质干细胞的方法，2009 年10 月28 日，中国， ZL200610050762.8。11.  黄河，来晓瑜，沈建根，单抗ZUF10 免疫磁珠分选人骨髓间充质干细胞的方法，2009 年11 月25 日，中国，ZL200610050763.2。12.  黄河，来晓瑜，沈建根，单抗ZUE12 免疫磁珠分选人骨髓间充质干细胞的方法，2009 年10 月28 日，中国，ZL200610050759.6。13.  黄河，来晓瑜，沈建根，罗依，抗人骨髓间充质干细胞单克隆抗体ZUF10 及应用，2008 年7 月2 日，中国，ZL200510061032.3。14.  黄河，来晓瑜，沈建根，罗依，抗人骨髓间充质干细胞单克隆抗体ZUC3 及应用，2008 年7 月2 日，中国，ZL200510061033.8。15.  黄河，来晓瑜，沈建根，罗依，抗人骨髓间充质干细胞单克隆抗体ZUB1 及应用，2008 年4 月16 日，中国，ZL200510061034.2。16.  黄河，来晓瑜，沈建根，罗依，抗人骨髓间充质干细胞单克隆抗体ZUE12 及应用，2008 年7 月2 日，中国，ZL200510061035.7。17.  黄河，来晓瑜，沈建根，罗依，抗人骨髓间充质干细胞单克隆抗体ZUB4 及应用，2008 年7 月2 日，中国，ZL200510061036.1。实验室介绍: